BFC Planning, Inc.’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BFC Planning, Inc.'s NVS Position: Q3 2026 in Review
BFC Planning, Inc. reduced its Novartis (NVS) stake by 3.5% in Q3 2026, selling an estimated $50.7K and leaving 9,242 shares worth $1.32M. The position accounts for 0.05% of the portfolio, ranked #329.
BFC Planning, Inc. first reported a position in NVS in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.5M in Q2 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- BFC Planning, Inc. held 9,242 shares of Novartis worth $1.32M as of Q3 2026.
- BFC Planning, Inc. sold 334 Novartis shares in Q3 2026, an estimated $50.7K.
- Novartis made up 0.05% of BFC Planning, Inc.'s portfolio in Q3 2026, its #329 holding.
- BFC Planning, Inc. first reported a position in Novartis in Q3 2024 and has held it in 9 quarters since.
- BFC Planning, Inc.'s Novartis position peaked at $1.5M in Q2 2026.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on BFC Planning, Inc.'s 13F filing for Q3 2026, filed 13 Nov 2026.